Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aida Santaolalla

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Cancers|November 13, 2021
Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-AnalysisMaria J Monroy-Iglesias, Charlotte Moss, Kerri Beckmann, et al.
Cancers|May 13, 2026
Associations Between Routinely Measured Biomarkers and Pancreatic Cancer Risk in Individuals with Type 2 Diabetes Pre- and Post-DiagnosisZiying Zhang, Sofia Carlsson, Niklas Hammar, et al.
Plos One|July 18, 2025
Effects of vitamin D on COVID-19 risk and hospitalisation in the UK biobankMaria J Monroy-Iglesias, Rathesh Thavarajah, Kerri Beckmann, et al.
BMC Cancer|May 20, 2021
Guy's and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance databaseSalonee Shah, Kerri Beckmann, Mieke Van Hemelrijck, et al.
BMC Immunology|September 7, 2021
Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS studyAida Santaolalla, Sam Sollie, Ali Rislan, et al.
BMC Molecular and Cell Biology|July 25, 2019
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysisAida Santaolalla, Hans Garmo, Anita Grigoriadis, et al.
BMC Cancer|January 25, 2022
Correction to: Guy's and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance databaseSalonee Shah, Kerri Beckmann, Mieke Van Hemelrijck, et al.
Prostate Cancer and Prostatic Diseases|August 25, 2022
Risk of progression following a negative biopsy in prostate cancer active surveillanceKerri Beckmann, Aida Santaolalla, Mikio Sugimoto, et al.
Frontiers in Artificial Intelligence|December 6, 2021
The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate CancerAida Santaolalla, Tim Hulsen, Jenson Davis, et al.
The Prostate|March 7, 2022
Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium databaseKerri R Beckmann, Chris H Bangma, Jozien Helleman, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cancers|November 13, 2021
Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-AnalysisMaria J Monroy-Iglesias, Charlotte Moss, Kerri Beckmann, et al.
Cancers|May 13, 2026
Associations Between Routinely Measured Biomarkers and Pancreatic Cancer Risk in Individuals with Type 2 Diabetes Pre- and Post-DiagnosisZiying Zhang, Sofia Carlsson, Niklas Hammar, et al.
Plos One|July 18, 2025
Effects of vitamin D on COVID-19 risk and hospitalisation in the UK biobankMaria J Monroy-Iglesias, Rathesh Thavarajah, Kerri Beckmann, et al.
BMC Cancer|May 20, 2021
Guy's and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance databaseSalonee Shah, Kerri Beckmann, Mieke Van Hemelrijck, et al.
BMC Immunology|September 7, 2021
Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS studyAida Santaolalla, Sam Sollie, Ali Rislan, et al.
BMC Molecular and Cell Biology|July 25, 2019
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysisAida Santaolalla, Hans Garmo, Anita Grigoriadis, et al.
BMC Cancer|January 25, 2022
Correction to: Guy's and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance databaseSalonee Shah, Kerri Beckmann, Mieke Van Hemelrijck, et al.
Prostate Cancer and Prostatic Diseases|August 25, 2022
Risk of progression following a negative biopsy in prostate cancer active surveillanceKerri Beckmann, Aida Santaolalla, Mikio Sugimoto, et al.
Frontiers in Artificial Intelligence|December 6, 2021
The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate CancerAida Santaolalla, Tim Hulsen, Jenson Davis, et al.
The Prostate|March 7, 2022
Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium databaseKerri R Beckmann, Chris H Bangma, Jozien Helleman, et al.
Pageof 5